German Pharma Stock News

XTRA:VOS
XTRA:VOSMachinery

Vossloh (XTRA:VOS) Earnings Growth And 5.1% Margin Test Bullish Narratives

Vossloh (XTRA:VOS) closed out FY 2025 with fourth quarter revenue of €434.7 million and net income of €27.7 million, equal to EPS of €1.03, while for the trailing twelve months it recorded revenue of €1.34b and EPS of €3.24. Over recent quarters, revenue has ranged from €251.1 million to €434.7 million, with quarterly EPS moving between €0.24 and €1.25, giving investors a view of how the top line and per share earnings have tracked through the year. With a trailing net margin of 5.1% and...
XTRA:VOW3
XTRA:VOW3Auto

Does Volkswagen’s Job Cuts and Tech Pivot Reshape the Bull Case For Volkswagen (XTRA:VOW3)?

Volkswagen AG previously announced it will pay an annual dividend of €5.26 per share on June 23, 2026, while pressing ahead with extensive restructuring and plans to cut about 50,000 jobs in Germany by 2030 to address high labor and energy costs and improve manufacturing productivity. At the same time, Volkswagen is reinforcing its push into software and data-driven services through a new fleet-data partnership with OCTO and expanding its electric SUV line-up in China with XPeng,...
XTRA:BAS
XTRA:BASChemicals

BASF’s Canola R&D Push and Dividend Steadiness Might Change The Case For Investing In BASF (XTRA:BAS)

BASF SE has affirmed an annual dividend of €2.25 per share payable on May 6, 2026, and earlier this month committed C$27 million to expand and modernise its Canola Breeding Centre of Innovation in Saskatoon with advanced automation and precision-controlled growth facilities. This investment underlines BASF’s push to strengthen its agricultural solutions franchise through faster development of new canola hybrids and enhanced research capabilities that support growers in North America, Europe...
XTRA:VNA
XTRA:VNAReal Estate

Vonovia (XTRA:VNA) Valuation Check After Swing Back To €3,723m Net Income In 2025 Results

Why Vonovia’s 2025 earnings are drawing fresh attention Vonovia (XTRA:VNA) has moved back into the spotlight after reporting full year 2025 earnings, shifting from a prior net loss to net income of €3,723 million and positive earnings per share. See our latest analysis for Vonovia. Despite the swing back to profit, the share price has fallen recently. It has a 7 day share price return of 14.8% and a 30 day share price return of 23.5%, while the 3 year total shareholder return of 42.4%...
XTRA:SAP
XTRA:SAPSoftware

A Look At SAP (XTRA:SAP) Valuation After Recent Share Price Weakness

SAP (XTRA:SAP) has drawn attention after a period of weak share performance, with the stock showing negative returns over the past month and past 3 months. This has prompted investors to reassess the software group’s fundamentals. See our latest analysis for SAP. At a share price of €153.86, SAP’s recent share price return shows a 7 day decline of 7.01% and a 30 day drop of 11.47%. The 1 year total shareholder return of a 39.20% decline contrasts with positive 3 and 5 year total shareholder...
XTRA:DBK
XTRA:DBKCapital Markets

Does Deutsche Bank’s Leadership Shuffle and Funding Strategy Shift Change The Bull Case For Deutsche Bank (XTRA:DBK)?

In March 2026, Deutsche Bank announced multiple Management Board and Group Management Committee changes, including elevating DWS CEO Stefan Hoops to the Group board, appointing Marie-Jeanne Deverdun as Chief Technology, Data and Innovation Officer, and naming Fabrizio Campelli as President, while also continuing to raise long-dated, callable senior unsecured fixed-rate funding through a series of US dollar and euro bond offerings. Taken together with disclosures about very large private...
XTRA:KRN
XTRA:KRNMachinery

Assessing Krones (XTRA:KRN) Valuation After Robust 2025 Results And Higher Dividend Announcement

Krones (XTRA:KRN) just paired fresh full year 2025 results with an annual dividend of €2.80 per share, payable on June 12, 2026, giving investors new income and earnings data to assess. See our latest analysis for Krones. The full year 2025 results and higher dividend come after mixed recent trading, with a 1 day share price return of 3.18%, a 30 day share price return of 13.61%, and a 1 year total shareholder return of 11.74%. This suggests that recent momentum has faded compared with longer...
XTRA:DHER
XTRA:DHERHospitality

Is Delivery Hero (XTRA:DHER) Offering Value After Share Price Slide To €16.50

If you are wondering whether Delivery Hero at €16.50 is starting to look like value, or if the risks still outweigh the potential reward, this article walks you through what the current price really implies. The stock has been under pressure, with a 1.6% decline over the past week, 19.2% decline over the past month, and 27.7% decline year to date, adding to a 31.1% decline over 1 year and 44.4% decline over 3 years. These moves sit against a backdrop of ongoing headlines around Delivery...
XTRA:DB1
XTRA:DB1Capital Markets

Assessing Deutsche Börse (XTRA:DB1) Valuation As Recent Share Price Momentum Cools

Deutsche Börse (XTRA:DB1) has come into focus after a recent move in its share price, with the stock showing mixed short term returns despite a positive month and past 3 months for investors watching its performance. See our latest analysis for Deutsche Börse. At a share price of €240.3, Deutsche Börse has seen a soft 1 day share price return of 1.23% and a 7 day share price return of 2.95%. This follows a stronger 30 day share price return of 9.28% and a year to date share price return of...
XTRA:SIE
XTRA:SIEIndustrials

Sizing Up Siemens (XTRA:SIE) Valuation After NVIDIA Industrial AI And Digital Twin Partnership

NVIDIA’s latest industrial AI announcement highlights Siemens (XTRA:SIE) as a core software partner, integrating GPU-accelerated tools, agentic AI and digital twin technology into semiconductor design, automotive engineering and large-scale industrial environments. See our latest analysis for Siemens. Despite the NVIDIA news putting Siemens’ AI and digital twin work in the spotlight, the 30-day share price return of 13.81% and year to date share price return of a 12.36% decline suggest...
XTRA:NDX1
XTRA:NDX1Electrical

Nordex Wins New European Orders As Share Price Trades Near Fair Value

Nordex has received several new turbine orders across Europe from a mix of existing and new clients. These include an order for 11 turbines in Serbia, repowering projects on the island of Fehmarn, and new community and developer partnerships in Germany. The orders highlight continued activity in repowering older sites and supporting community based wind projects. For investors tracking XTRA:NDX1, the latest orders come with the share price at €44.26 and multi year share price gains,...
XTRA:BC8
XTRA:BC8IT

Why Bechtle (XTRA:BC8) Is Down 14.9% After Beating 2025 Guidance But Posting Lower Earnings

Bechtle AG has released its 2025 results, reporting full-year sales of €6,405.87 million, net income of €229.21 million and basic earnings per share from continuing operations of €1.82, alongside a proposed dividend of €0.70 per share. Despite lower net income year-on-year, Bechtle exceeded its own guidance with 8% business volume growth, a record December above €1 billion in volume, and new multi-cloud and public sector agreements that could reshape its longer-term growth profile. Now we’ll...
XTRA:BAYN
XTRA:BAYNPharmaceuticals

Assessing Bayer (XTRA:BAYN) Valuation After Positive FIND-CKD Results For Kerendia

Why the FIND-CKD result matters for Bayer stock Bayer (XTRA:BAYN) has drawn fresh attention after its Phase III FIND-CKD study for Kerendia in non-diabetic chronic kidney disease met its primary endpoint, potentially widening the drug’s addressable patient pool. See our latest analysis for Bayer. The FIND-CKD news has arrived against a mixed backdrop for Bayer, with a 30 day share price return of 12.12% decline but a 1 year total shareholder return of 72.11% and a weaker 3 year total...
XTRA:AFX
XTRA:AFXMedical Equipment

Carl Zeiss Meditec’s FTSE All-World Exit Might Change The Case For Investing In (XTRA:AFX)

Carl Zeiss Meditec AG (Xetra: AFX) was recently removed as a constituent from the FTSE All-World Index (USD), marking a change in its inclusion within a widely followed global benchmark. This index exit may influence how some institutional investors view the company’s market profile, potentially affecting future index-linked investment flows and liquidity. We’ll now examine how Carl Zeiss Meditec’s removal from the FTSE All-World Index could affect its previously outlined investment...
XTRA:ELG
XTRA:ELGSemiconductor

Assessing Elmos Semiconductor (XTRA:ELG) Valuation As Recent Momentum Meets Conflicting Fair Value Signals

Elmos Semiconductor (XTRA:ELG) has drawn investor attention after recent share price moves, with the stock showing mixed short term performance and a stronger pattern over the month and past 3 months. See our latest analysis for Elmos Semiconductor. With the share price now at €139.2 and a 90 day share price return of 52.97%, Elmos Semiconductor has paired strong recent momentum with a 1 year total shareholder return of 113.49%. This points to a shift in how the market is pricing its growth...
XTRA:OHB
XTRA:OHBAerospace & Defense

Assessing OHB SE (XTRA:OHB) Valuation After Swing Back To Profit And Strong Full Year 2025 Results

OHB (XTRA:OHB) is back in focus after its full year 2025 results, reporting sales of €1,233.74 million and revenue of €1,247.6 million, along with a swing from a small net loss to a €49.53 million profit. See our latest analysis for OHB. The earnings swing back to profit has arrived alongside sharp share price momentum, with a 90 day share price return of 113.11% and a 1 year total shareholder return of 270.12%, pointing to investors rapidly re-rating the company’s prospects. If you are...
XTRA:FPE3
XTRA:FPE3Chemicals

Fuchs (XTRA:FPE3) Higher 8.6% Net Margin Tests Concerns Over Slower Revenue Growth

Fuchs (XTRA:FPE3) FY 2025 earnings snapshot Fuchs (XTRA:FPE3) has wrapped up FY 2025 with fourth quarter revenue of €863 million and net income of €78 million, while trailing twelve month revenue came in at €3.6 billion and net income at €306 million, framing a steady earnings picture. Over the past few quarters, the company has seen quarterly revenue move between €859 million and €924 million, with quarterly net income ranging from €67 million to €84 million. This gives a clear sense of how...
XTRA:KRN
XTRA:KRNMachinery

Krones (XTRA:KRN) Margin Improvement To 5.2% Tests Bullish Expansion Narrative

Recent Earnings Snapshot Krones (XTRA:KRN) has opened FY 2025 with steady top and bottom line figures, with third quarter revenue at about €1.4b and basic EPS of €2.15, set against trailing 12 month EPS of €9.17 on revenue of roughly €5.6b and earnings growth of 16.1% over the past year. The company has seen quarterly revenue fluctuate in a relatively tight band between €1.3b and €1.4b since early 2024, while basic EPS has ranged from €2.08 to €2.40 over the same period, feeding into a...
XTRA:MBG
XTRA:MBGAuto

Is Mercedes-Benz Group (XTRA:MBG) Recasting Korea Leadership To Sharpen Its Global Premium Sales Edge?

Mercedes-Benz Korea has appointed Shirin Emeera, a seasoned sales network specialist at Mercedes-Benz AG, as its new CEO, succeeding Mathias Vaitl, who will move to lead Marketing & Sales Vans at Mercedes-Benz AG from July 1, 2026. This leadership transition underscores Mercedes-Benz’s intent to deepen its footprint in South Korea by pairing local growth initiatives with experienced global sales leadership. We’ll now examine how installing a sales-focused CEO in South Korea could influence...
XTRA:UN0
XTRA:UN0Renewable Energy

Uniper (XTRA:UN0) Is Up 11.6% After Profit Surges Despite Lower Sales Is The Bull Case Changing?

Uniper SE recently reported its full-year 2025 results, with sales of €61,283 million versus €69,978 million a year earlier and net income of €1,397 million compared with €297 million, lifting basic earnings per share from continuing operations to €3.35 from €0.71. The sharp rise in net income despite lower sales highlights a marked improvement in profitability, which raises questions about the sustainability and drivers of this performance shift. We will now examine how this substantial...
XTRA:LHA
XTRA:LHAAirlines

A Look At Deutsche Lufthansa (XTRA:LHA) Valuation After Recent Share Price Weakness

Recent share performance and business scale Deutsche Lufthansa (XTRA:LHA) has seen its share price move lower recently, with a 1 day return of 1.16%, 7 day return of 3.44%, month return of 20.09% and past 3 months return of 14.31%. Year to date, the stock shows a 14.43% decline, while the 1 year total return is 4.07% and the 3 year total return is 14.00%, compared with a 5 year total return of 3.23%. The company reports annual revenue of €39.663b and net income of €1.332b, with annual revenue...